These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21790846)

  • 1. Scleroderma and raynaud's phenomenon improve with high-peak power laser therapy: a case report.
    St Surin-Lord S; Obagi S
    Dermatol Surg; 2011 Oct; 37(10):1531-5. PubMed ID: 21790846
    [No Abstract]   [Full Text] [Related]  

  • 2. Raynaud's phenomenon and scleroderma; a case report and psychodynamic formulation.
    RICHARDSON HB
    Psychoanal Rev; 1955 Jan; 42(1):24-38. PubMed ID: 14371880
    [No Abstract]   [Full Text] [Related]  

  • 3. [Raynaud's phenomenon and scleroderma (author's transl)].
    Merlen JF
    Ann Cardiol Angeiol (Paris); 1980 Jun; 29(4):333-7. PubMed ID: 7447353
    [No Abstract]   [Full Text] [Related]  

  • 4. [Raynaud's phenomenon and systemic scleroderma].
    Fiessinger JN; Housset E
    Rev Prat; 1975 May; 25(25):1989-92, 1997-8. PubMed ID: 1135587
    [No Abstract]   [Full Text] [Related]  

  • 5. Migraine and systemic scleroderma.
    Goldberg NC; Duncan SC; Winkelmann RK
    Arch Dermatol; 1978 Apr; 114(4):550-1. PubMed ID: 646367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic scleroderma in children].
    Plantin P; Gavanou J; Le Fur JM; Guillet G
    Arch Fr Pediatr; 1988 Dec; 45(10):805-8. PubMed ID: 3266459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Raynaud's phenomenon in the tongue of a patient with sclerodermia].
    Klemp P; Staberg B; Thomsen K
    Ugeskr Laeger; 1983 Jan; 145(5):333. PubMed ID: 6845496
    [No Abstract]   [Full Text] [Related]  

  • 9. Scleroderma, the heart and myocardial Raynaud's phenomenon.
    Nath AR; Mehta PJ
    J Assoc Physicians India; 1993 Oct; 41(10):631-2. PubMed ID: 8294319
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Scleroderma and Raynaud's phenomenon: current pathogenetic interpretations and clinico-therapeutic trends].
    Zelli GP; Cannata P
    Ann Ital Chir; 1981; 53(3):337-43. PubMed ID: 7337317
    [No Abstract]   [Full Text] [Related]  

  • 12. Paroxysmal dysarthria and Raynaud's phenomenon in the tongue.
    Nielsen HV; Kristensen JK; Klemp P; Staberg B; Thomsen K
    Acta Med Scand; 1984; 216(4):431-2. PubMed ID: 6516913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peculiarities in dermatology. A case of the Thiebierge-Weissen-bach type of systemic scleroderma associated with circumscribed calcinosis and Raynaud's disease.
    Kingsley HJ
    Cent Afr J Med; 1968 Mar; 14(3):59-60. PubMed ID: 5649072
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incomplete Raynaud's syndrome with extensive osteolysis, acrosclerosis, multiple visceral lesions. Systemic scleroderma].
    Michel PJ; Frieh P; Cretin J; Cassin B
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(4):526-31. PubMed ID: 5585213
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of Raynaud's phenomenon in systemic scleroderma: comparative study with that in vibration disease].
    Maeda M; Shikano Y; Mori S
    Nihon Hifuka Gakkai Zasshi; 1989 Nov; 99(12):1255-9. PubMed ID: 2622060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of nifedipine in Raynaud's phenomenon associated with systemic sclerosis.
    Thakur SK; Gopinathan VP; Jagdish TK; Bhalla IP; Shetty KJ
    J Assoc Physicians India; 1986 Jul; 34(7):536. PubMed ID: 3759897
    [No Abstract]   [Full Text] [Related]  

  • 19. [Scleroderma, pulmonary hypertension and Raynaud's syndrome].
    Duclós F; Bohórquez A; Zambrano A; Armenta J
    Rev Esp Cardiol; 1968 Apr; 21(2):223-33. PubMed ID: 5739705
    [No Abstract]   [Full Text] [Related]  

  • 20. Scleroderma and Raynaud's phenomenon.
    BARNETT AJ
    Clin Rep; 1959; 9():33-74. PubMed ID: 13796900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.